According to FutureWise analysis the market for Interventional Oncology in 2023 was US$ 2.03 billion, and is expected to reach US$ 3.5 billion by 2031 at a CAGR of 7.02%.

Interventional oncology deals with image guidance carrying minimally invasive medical procedures for diagnosis, palliation and treatment of various cancer types. Various image-guiding techniques like fluoroscopy, ultrasound and computed tomography are implemented in interventional oncology procedures to treat and diagnose a particular site that is affected with cancer or pain. This procedure is often performed with other cancer treatments like chemotherapy, radiation therapy and surgery. Interventional oncological procedures offer multiple advantages like shorter hospital stays, quick recovery, more precise treatment and minimal side effects.

Technological advancements in interventional oncology, advantages of minimally invasive surgical procedures and increase in the funds offered by the government are some factors that have assisted in the proliferation of the market.Product-wise, the market is fragmented into embolization devices, non-radioactive embolic agents, ablation devices, support devices and guidewires. The ablation devices segment is further segmented into radiofrequency ablation devices, microwave ablation devices, cryoablation devices. The embolization devices segment is anticipated to register a remarkable CAGR during the forecast period. The process of embolization has multiple benefits which is why it is primarily preferred worldwide. It is the process of embolus lodging inside the bloodstream to block the blood supply to the tumour. The blood vessels are selectively occluded by introducing emboli using irradiation or chemical techniques.

Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Interventional-Oncology-Market/2336

Interventional Oncology Market Segmentation:

By Product

Embolization Devices
Radioembolic Agents
Non-Radioactive Embolic Agents
Ablation Devices
Radiofrequency Ablation Devices
Microwave Ablation Devices
Cryoablation Devices
Other Ablation Devices
Support Devices
Microcatheters
Guidewires

By Procedure

Thermal Tumour Ablation
Non-thermal Tumour Ablation
Transcatheter Arterial Chemoembolization
Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
Transcatheter Arterial Embolization/Bland Embolization

By Cancer Type

Liver Cancer
Lung Cancer
Bone Cancer
Kidney Cancer
Other Cancers

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Competitive Landscape in Interventional Oncology Market:

Medtronic
Boston Scientific
BTG Plc.
Terumo
Merit Medical
Sirtex
Ethicon
Cook Medical
Teleflex
HealthTronics
MedWaves Medical
IceCure Medical
Interface Biomaterial BV
Mermaid Medicals
ABK Biomedical
Guerbet
Endo Shape
Instylla
Shape Memory Medical
Monteris Medical
Trisalus Lifesciences

Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=2336%20&type=discount

**Objectives of this Study: **

To provide a comprehensive analysis of the Interventional Oncology Market By Product, By Procedure, By Cancer Type and By Region.
To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
The customization services offered are free of charge with the purchase of any license of the report.
You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com